dermatan sulfate has been researched along with Graft-Versus-Host Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doisaki, S; Kato, K; Matsumoto, K; Muramatsu, H; Sakaguchi, H; Watanabe, N; Yoshida, N | 1 |
1 other study(ies) available for dermatan sulfate and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy.
Topics: Adolescent; Child; Child, Preschool; Chondroitin Sulfates; Dermatan Sulfate; Female; Fibrinolytic Agents; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Heparitin Sulfate; Hepatic Veno-Occlusive Disease; Humans; Infant; Male; Prognosis; Retrospective Studies; Survival Rate; Transplantation, Homologous | 2010 |